What is Proviron (Mesterolone)?

Proviron is the brand name for mesterolone, an oral DHT (dihydrotestosterone) derivative. It is unique among oral AAS in that it is NOT 17α-alkylated — instead it uses a 1α-methyl group for oral bioavailability, resulting in significantly less hepatotoxicity than most oral steroids. It is used medically for male hypogonadism in some European countries.

How does Proviron work as an anti-estrogen?

Mesterolone binds strongly to sex hormone-binding globulin (SHBG) and competes with estrogen for binding sites. By displacing estrogen from SHBG, it reduces the bound estrogen available to exert estrogenic effects. It also has weak aromatase inhibitory activity. It does NOT block estrogen receptors like a SERM — its anti-estrogenic effect is SHBG-mediated.

Does Proviron increase free testosterone?

Indirectly, yes. By strongly binding SHBG, mesterolone displaces testosterone from its binding sites, increasing the free (bioavailable) fraction of testosterone. This is particularly useful when stacked with other compounds, as it maximizes the free testosterone available for receptor binding.

Is Proviron liver-safe?

Relatively speaking, yes. Mesterolone is one of the few oral AAS that is NOT 17α-alkylated. Its 1α-methyl modification provides oral bioavailability with significantly less hepatic stress than Dianabol, Anavar, or Winstrol. However, liver monitoring is still advisable at higher doses or prolonged use.

Anabolic Steroid • Oral DHT Derivative • Schedule III

Proviron: The SHBG Binder — Educational Reference

By MeetPeptide Research Team

Last updated: March 2026

Mesterolone (Proviron) is a unique oral DHT derivative — not 17α-alkylated, relatively liver-mild, weakly anabolic, and used primarily for its SHBG-binding anti-estrogenic effects and free testosterone enhancement. Used medically for male hypogonadism in Europe. This reference covers its pharmacology, mechanisms, and harm reduction context.

100–150:30–40

Anabolic:Androgenic Ratio
(vs testosterone = 100:100)

25–75mg

Reported Daily Dose
Oral (not 17α-alkylated)

12 hrs

Half-Life
Twice-daily dosing common

Mechanism of Action

How Mesterolone Works

Proviron's value is not in direct anabolism — it's in what it does to the hormonal environment around it. By binding SHBG and competing with aromatization, it acts as a hormonal adjunct rather than a primary anabolic.

🔗

SHBG Binding — Frees Testosterone

Mesterolone has extremely high binding affinity for sex hormone-binding globulin (SHBG) — comparable to DHT. By occupying SHBG binding sites, it displaces testosterone, increasing the free (unbound, bioavailable) fraction. In hypogonadal men with high SHBG, this can meaningfully increase free testosterone bioavailability without changing total testosterone levels.

🚫

Weak Aromatase Inhibition

Mesterolone has weak competitive aromatase inhibitory activity — it can partially compete with testosterone at the aromatase enzyme, reducing estradiol conversion. This effect is modest compared to dedicated AIs (anastrozole, exemestane) but contributes to its overall anti-estrogenic profile when combined with its SHBG displacement mechanism.

🫀

1α-Methylation — Not 17α-Alkylated

Unlike most oral AAS, mesterolone achieves oral bioavailability via a 1α-methyl group rather than 17α-alkylation. This dramatically reduces hepatic stress. Liver enzyme elevation does occur at high doses or prolonged use, but the hepatotoxic risk is significantly lower than Dianabol, Anavar, or Winstrol. This makes it uniquely liver-friendly among oral androgens.

💊

Weak Direct Anabolism

Mesterolone has a reasonable anabolic ratio on paper (~100–150) but poor real-world anabolic effect due to very high SHBG affinity — it binds SHBG more than it binds androgen receptors in muscle tissue. It is rapidly inactivated in muscle. Its primary clinical use was male hypogonadism and fertility enhancement (it maintains spermatogenesis unlike supraphysiological AAS).

Research Data

What Clinical Research Shows

Data from hypogonadism trials, fertility studies, and pharmacological research on mesterolone.

Free Testosterone Increase (SHBG displacement)

At 75mg/day in hypogonadal men with elevated SHBG

+20–30% free fraction

Estradiol Reduction

Combined SHBG + weak AI effect

10–20% reduction

Hepatotoxicity vs Dianabol (relative)

1α-methyl vs 17α-methyl — dramatically lower liver stress

~20% of Dianabol risk

HPTA Suppression

LH/FSH suppression — less than most AAS at typical doses

MILD–MODERATE

Sperm Quality Impact

Used in some fertility protocols — less suppressive than most AAS

Minimal at low doses

Safety Profile

Side Effects & Risks

Hepatotoxicity

1α-methyl — significantly lower than 17α-alkylated compounds

LOW (relative)

Androgenic Side Effects (acne, hair loss)

DHT derivative — androgenic effects present at higher doses

MODERATE

Cardiovascular Risk

HDL suppression occurs — less than most AAS but present

LOW–MODERATE

Virilization in Women

DHT derivative — virilization risk present; not recommended for women

MODERATE–HIGH

Bottom Line

Key Takeaways

✅ What We Know

Not 17α-alkylated — significantly less hepatotoxic than most oral AAS
Strong SHBG binding increases free testosterone fraction
Weak anti-estrogenic effect via SHBG displacement + mild AI activity
12-hour half-life — twice daily dosing
Weakly anabolic on its own — primarily used as a stack adjunct
Used medically for male hypogonadism and some fertility protocols in Europe
Still suppresses HPTA (though less than most AAS) — PCT may be needed

⚠️ What We Don't Know

Optimal dosing for SHBG reduction in different individual contexts
Whether anti-estrogenic effect is clinically meaningful vs dedicated AIs
Long-term prostate effects (DHT derivative — BPH concern)
Interaction effects in complex stacks poorly characterized
Whether it provides meaningful anabolic benefit at any dose

📚

Want the Complete Protocol Guide?

Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.

Get the Guide →

⚠️ Legal & Medical Disclaimer

This page is for educational and harm reduction purposes only. It is not medical advice. Mesterolone (Proviron) is a Schedule III controlled substance in the United States. While it has medical applications in some European countries, it is not FDA-approved for use in the US. It is banned by WADA and all major sports organizations. Use carries health risks including androgenic effects, HPTA suppression, and cardiovascular changes. Consult a qualified physician before any decisions regarding hormone use. MeetPeptide does not endorse or encourage the use of controlled substances.